Alpine Immune Sciences Inc (ALPN)
64.95
0.00 (0.00%)
USD |
NASDAQ |
May 14, 16:00
64.13
-0.82
(-1.26%)
Pre-Market: 20:00
Alpine Immune Sciences 1 Year Total Returns (Daily): 695.0% for May 14, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 14, 2024 | 695.0% |
May 13, 2024 | 695.0% |
May 10, 2024 | 725.2% |
May 09, 2024 | 779.5% |
May 08, 2024 | 765.0% |
May 07, 2024 | 774.7% |
May 06, 2024 | 774.2% |
May 03, 2024 | 824.2% |
May 02, 2024 | 812.4% |
May 01, 2024 | 762.5% |
April 30, 2024 | 762.3% |
April 29, 2024 | 763.8% |
April 26, 2024 | 795.4% |
April 25, 2024 | 811.4% |
April 24, 2024 | 801.8% |
April 23, 2024 | 801.5% |
April 22, 2024 | 802.0% |
April 19, 2024 | 765.3% |
April 18, 2024 | 762.5% |
April 17, 2024 | 765.2% |
April 16, 2024 | 782.4% |
April 15, 2024 | 781.3% |
April 12, 2024 | 787.9% |
April 11, 2024 | 755.2% |
April 10, 2024 | 507.0% |
Date | Value |
---|---|
April 09, 2024 | 414.4% |
April 08, 2024 | 409.0% |
April 05, 2024 | 368.0% |
April 04, 2024 | 369.2% |
April 03, 2024 | 371.1% |
April 02, 2024 | 407.9% |
April 01, 2024 | 421.0% |
March 28, 2024 | 449.0% |
March 27, 2024 | 452.1% |
March 26, 2024 | 402.7% |
March 25, 2024 | 404.0% |
March 22, 2024 | 397.3% |
March 21, 2024 | 419.4% |
March 20, 2024 | 393.0% |
March 19, 2024 | 365.1% |
March 18, 2024 | 312.9% |
March 15, 2024 | 352.5% |
March 14, 2024 | 356.0% |
March 13, 2024 | 393.4% |
March 12, 2024 | 404.1% |
March 11, 2024 | 389.3% |
March 08, 2024 | 341.4% |
March 07, 2024 | 352.3% |
March 06, 2024 | 384.3% |
March 05, 2024 | 369.0% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-68.73%
Minimum
Mar 17 2020
824.2%
Maximum
May 03 2024
69.22%
Average
1.17%
Median
Feb 09 2023
1 Year Total Returns (Daily) Benchmarks
Vertex Pharmaceuticals Inc | 23.37% |
Eliem Therapeutics Inc | 155.9% |
Regeneron Pharmaceuticals Inc | 32.28% |
Vera Therapeutics Inc | 439.9% |
Eyenovia Inc | -76.12% |